Src inhibitors are promising therapy molecules for human cervical carcinomas

Medical Hypotheses

Volumn 77, Issue 5, 2011, Pages 812-814

  Al Moustafa, Ala Eddin ^a,b,c   Yasmeen, Amber ^b   Achkhar, Amal ^a,d  

^a Syrian Research Cancer Centre of the Syrian Society against Cancer   (Syrian Arab Republic)

^b MCGILL UNIVERSITY   (Canada)

^c Gina Cody School of Engineering and Computer Science   (Canada)

^d UNIVERSITY OF ALEPPO   (Syrian Arab Republic)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN E6; PROTEIN E7; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR;

ARTICLE; ENZYME ACTIVITY; UTERINE CERVIX CARCINOMA; WART VIRUS;

FEMALE; HUMANS; PROTEIN KINASE INHIBITORS; SRC-FAMILY KINASES; UTERINE CERVICAL NEOPLASMS;

ANIMALIA; HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 80053939179     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.07.043     Document Type: Article

References (27)

1. Muñoz N., Bosch F.X., Castellsagué X., Díaz M., de Sanjose S., Hammouda D., et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004, 111:278-285.
2. Tjalma W.A., Van Waes T.R., Van den Eeden L.E., Bogers J.J. Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix. Best Pract Res Clin Obstet Gynaecol 2005, 19:469-483.
3. de Sanjosé S., Diaz M., Castellsagué X., Clifford G., Bruni L., Muñoz N., et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007, 7:453-459.
4. Vousden K.H. Regulation of the cell cycle by viral oncoproteins. Semin Cancer Biol 1995, 6:109-116.
5. Scheffner M., Huibregtse J.M., Vierstra R.D., Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993, 75:495-505.
6. Dyson N., Howley P.M., Munger K., Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989, 243:934-937.
7. Dyson N., Guida P., Munger K., Harlow E. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol 1992, 66:6893-6902.
8. del Campo J.M., Prat A., Gil-Moreno A., Pérez J., Parera M. Update on novel therapeutic agents for cervical cancer. Gynecol Oncol 2008, 110:S72-S76.
9. Yasmeen A., Bismar T.A., Al Moustafa A.E. ErbB receptors and epithelial-cadherin-catenin complex in human carcinomas. Future Oncol 2006, 2:765-781.
10. Al Moustafa A.E., Kassab A., Darnel A., Yasmeen A. High-risk HPV/ErbB-2 interaction on E-cadherin/catenin regulation in human carcinogenesis. Curr Pharm Des 2008, 14:2159-2172.
11. Goncalves A., Fabbro M., Lhommé C., Gladieff L., Extra J.M., Floquet A., et al. A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer. Gynecol Oncol 2008, 108:42-46.
12. Frame M.C. Src in cancer: deregulation and consequences for cell behaviour. Biochim Biophys Acta 2002, 1602:114-130.
13. Manavi M., Hudelist G., Fink-Retter A., Gschwandtler-Kaulich D., Pischinger K., Czerwenka K. Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma. Gynecol Oncol 2007, 105:418-426.
14. Hirano S., Ito N., Takahashi S., Tamaya T. Clinical implications of insulin-like growth factors through the presence of their binding proteins and receptors expressed in gynecological cancers. Eur J Gynaecol Oncol. 2004, 25:187-191.
15. Hu G., Liu W., Mendelsohn J., Ellis L.M., Radinsky R., Andreeff M., et al. Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells. J Natl Cancer Inst 1997, 89:1271-1276.
16. Wilding J., Vousden K.H., Soutter W.P., McCrea P.D., Del Buono R., Pignatelli M. E-cadherin transfection down-regulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus-transfected keratinocytes. Cancer Res 1996, 56:5285-5292.
17. Kersemaekers A.M., Fleuren G.J., Kenter G.G., Van den Broek L.J., Uljee S.M., Hermans J., et al. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis. Clin Cancer Res 1999, 5:577-586.
18. Baldwin A., Huh K.W., Münger K. Human papillomavirus E7 oncoprotein dysregulates steroid receptor coactivator 1 localization and function. J Virol 2006, 80:6669-6677.
19. Thomas S.M., Brugge J.S. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 1997, 13:513-609.
20. Thiery J.P., Morgan M. Breast cancer progression with a Twist. Nat Med 2004, 10:777-778.
21. Johnson F.M., Gallick G.E. SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy. Anticancer Agents Med Chem 2007, 7:651-659.
22. Schmidmaier R., Baumann P. ANTI-ADHESION evolves to a promising therapeutic concept in oncology. Curr Med Chem 2008, 15:978-990.
23. Yasmeen A, Alachkar A, Dekhil H, Gambacorti-Passerini C, Al Moustafa AE. Locking Src/Abl tyrosine kinase activities regulate cell differentiation and invasion of aggressive cervical cancer cells. J Oncol. 2010; published online on Aug 25, 2010.
24. Shai A., Brake T., Somoza C., Lambert P.F. The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities. Cancer Res 2007, 67:1626-1635.
25. Al Moustafa A.E., Foulkes W.D., Wong A., Jallal H., Batist G., Yu Q., et al. Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells. Oncogene 2004, 23:5252-5256.
26. Araujo J., Logothetis C. Targeting Src signaling in metastatic bone disease. Int J Cancer 2009, 124:1-6.
27. Ma W.W., Adjei A.A. Novel agents on the horizon for cancer therapy. CA Cancer J Clin 2009, 59:111-137.